Table 3 Univariate and multivariate regression analyses for predictors of poor outcome (mRS > 2)
From: The “SALPARE study” of spontaneous intracerebral hemorrhage: part 1
Univariate | Multivariate | |||
|---|---|---|---|---|
Variables | P value | OR | P value | OR |
Premorbid mRS ≥ 1 | 0.00000 | 4.88 (2.82–8.44) | 0.00000 | 30.84 |
Previous cerebrovascular accident | 0.00659 | 2.12 (1.22–3.71) | ||
Ongoing anticoagulant therapy | 0.05106 | 1.71 (0.99–2.96) | ||
Ongoing antiplatelet therapy | 0.00654 | 1.86 (1.18–2.93) | ||
Blood glucose level > 180 mg/dl | 0.00016 | 3.48 (1.76–6.90) | ||
Platelet count < 100/mm3 | 0.01093 | 8.72 (1.17–64.62) | ||
GCS score at the onset ≤ 14 | 0.00000 | 8.92 (5.46–14.58) | 0.00000 | 11.88 |
NIHSS score at the onset ≥ 9 | 0.00000 | 8.93 (5.43–14.67) | 0.001 | 25.89 |
Pontine or massive hemorrhage | 0.01374 | 1.24 (1.09–2.75) | ||
Intraventricular bleeding | 0.00000 | 3.94 (2.52–6.16) | ||
Baseline hematoma volume > 15 ml | 0.00000 | 6.67 (4.15–10.72) | 0.00000 | 29.71 |
Hematoma expansion (i.e. > 30%) | 0.00087 | 2.42 (1.42–4.11) | ||